The family functioning in adolescence questionnaire: a measure of psychosocial family health during adolescenceROELOFSE, R; MIDDLETON, M. R.Journal of adolescence. 1985, Vol 8, Num 1, pp 33-45, issn 0140-1971Article

Dose intensification in small cell lung cancer chemotherapyMIDDLETON, M. R; THATCHER, N.Emerging drugs. 1998, Vol 3, pp 293-301, issn 1361-9195Article

Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY studyLORIGAN, P; MARPLES, M; PERICLEOUS, L et al.British journal of dermatology (1951). 2014, Vol 170, Num 1, pp 87-95, issn 0007-0963, 9 p.Article

A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecanMIDGLEY, R. S; KERR, D. J; O'DWYER, P. J et al.Annals of oncology. 2007, Vol 18, Num 12, pp 2025-2029, issn 0923-7534, 5 p.Article

The pitting and cracking of SAE 52100 steel in rolling/sliding contact in the presence of an aqueous lubricant^©SULLIVAN, J. L; MIDDLETON, M. R.ASLE transactions. 1985, Vol 28, Num 4, pp 431-438, issn 0569-8197Article

Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumorsMACAULAY, V. M; MIDDLETON, M. R; SORIA, J.-C et al.Annals of oncology. 2013, Vol 24, Num 3, pp 784-791, issn 0923-7534, 8 p.Article

Phase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumoursDEAN, E; MIDDLETON, M. R; PWINT, T et al.British journal of cancer. 2012, Vol 106, Num 3, pp 468-474, issn 0007-0920, 7 p.Article

O⁶-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatribWATSON, A. J; MIDDLETON, M. R; HAYDON, A et al.British journal of cancer. 2009, Vol 100, Num 8, pp 1250-1256, issn 0007-0920, 7 p.Article

Role of positron emission tomography―computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinomaGILLIES, R. S; MIDDLETON, M. R; HAN, C et al.British journal of surgery. 2012, Vol 99, Num 2, pp 239-245, issn 0007-1323, 7 p.Article

A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancerSABHARWAL, A; CORRIE, P. G; MIDGLEY, R. S et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 5, pp 829-835, issn 0344-5704, 7 p.Article

Adjuvant interferon in high-risk melanoma: The AIM HIGH study: United Kingdom coordinating committee on cancer research randomized study of adjuvant low-dose extended-duration interferon alfa-2a in high-risk resected malignant melanomaHANCOCK, B. W; WHEATLEY, K; BURROWS, L et al.Journal of clinical oncology. 2004, Vol 22, Num 1, pp 53-61, issn 0732-183X, 9 p.Article

A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanomaMIDDLETON, M. R; LORIGAN, P; OWEN, J et al.British journal of cancer. 2000, Vol 82, Num 6, pp 1158-1162, issn 0007-0920Article

Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trialCUMMINGS, J; ZWEIFEL, M; SMITH, N et al.British journal of cancer. 2012, Vol 106, Num 11, pp 1766-1771, issn 0007-0920, 6 p.Article

Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancerKHAN, O. A; BLANN, A. D; PAYNE, M. J et al.British journal of cancer. 2011, Vol 104, Num 12, pp 1822-1827, issn 0007-0920, 6 p.Article

A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumoursBLAGDEN, S. P; MOLIFE, L. R; HODGE, J. P et al.British journal of cancer. 2008, Vol 98, Num 5, pp 894-899, issn 0007-0920, 6 p.Article

High-intensity focused ultrasound ablation of liver tumours : can radiological assessment predict the histological response?LESLIE, T. A; KENNEDY, J. E; ILLING, R. O et al.British journal of radiology. 2008, Vol 81, Num 967, pp 564-571, issn 0007-1285, 8 p.Article

Randomized phase II study of Temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanomaDANSON, S; LORIGAN, P; ARANCE, A et al.Journal of clinical oncology. 2003, Vol 21, Num 13, pp 2551-2557, issn 0732-183X, 7 p.Article

DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanomaGUPTA, A; LOVE, S; COLLINS, L et al.Annals of oncology. 2014, Vol 25, Num 5, pp 968-974, issn 0923-7534, 7 p.Article

A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanomaKEFFORD, R. F; THOMAS, Npb; MARGISON, G. P et al.British journal of cancer. 2009, Vol 100, Num 8, pp 1245-1249, issn 0007-0920, 5 p.Article

The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western populationILLING, R. O; KENNEDY, J. E; WU, F et al.British journal of cancer. 2005, Vol 93, Num 8, pp 890-895, issn 0007-0920, 6 p.Article

Post hoc economic analysis of temozolomide versus dacarbazine in the treatment of advanced metastatic melanomaHILLNER, B. E; AGARWALA, S; MIDDLETON, M. R et al.Journal of clinical oncology. 2000, Vol 18, Num 7, pp 1474-1480, issn 0732-183XArticle

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanomaMIDDLETON, M. R; GROB, J. J; DRENO, B et al.Journal of clinical oncology. 2000, Vol 18, Num 1, pp 158-166, issn 0732-183XArticle

O⁶-Methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanomaMIDDLETON, M. R; LUNN, J. M; NEWLANDS, E. S et al.British journal of cancer. 1998, Vol 78, Num 9, pp 1199-1202, issn 0007-0920Article

Toxic epidermal necrolysis in a patient receiving vemurafenib for treatment of metastatic malignant melanomaSINHA, R; LECAMWASAM, K; PURSHOUSE, K et al.British journal of dermatology (1951). 2014, Vol 170, Num 4, pp 997-999, issn 0007-0963, 3 p.Article

A phase I study of the safety and tolerability of olaparib (AZD228I, KU0059436) and dacarbazine in patients with advanced solid tumoursKHAN, O. A; GORE, M; MARGISON, G. P et al.British journal of cancer. 2011, Vol 104, Num 5, pp 750-755, issn 0007-0920, 6 p.Article